jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Forum Article

Nonviral gene delivery system

Ningning Yang1★★ Corresponding author

  1. 1Department of Pharmaceutical Sciences, Manchester University College of Pharmacy, 10627 Diebold Road, Fort Wayne, IN 46845, USA.

CORRESPONDENCE

Ningning Yang

Department of Pharmaceutical Sciences, Manchester University College of Pharmacy, 10627 Diebold Road, Fort Wayne, IN 46845, USA.

nyang@manchester.edu

Volume 2, Issue 3 · pp. 97–98 · PUBLISHED · DOI: 10.4103/2230-973X.104388

View on IJPI original site ↗

ABSTRACT

Gene therapy has been investigated a lot in both basic research and clinical trials.[1] The first antisense oligodeoxyribonucleotide (ODN) drug, Vitravene (Fomivirsen), was approved by the United States Food and Drug Administration (FDA) in 2005.[2] After this approval, more and more clinical trials are conducted, not only for ODNs, but also for other nucleic acids drugs, such as plasmid vectors and small interference RNAs (siRNAs).

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Yang, N. (). Nonviral gene delivery system. International Journal of Pharmaceutical Investigation, 2(3), 97–98. https://doi.org/10.4103/2230-973X.104388